NVST
EnvistaBNYSE / Health Care Equipment & Services
Last Price
At close
2026-07-22
Current thesis
Execution on product rollouts and an uptick in procedure volumes could push Envista toward the high end of sell-side targets; successful margin expansion or meaningful share gains in consumables would support upside to or above the analyst high.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.2.
What can break
Adverse FX moves or rising raw-material costs compressing margins
Momentum
59
Value
60
Sentiment
48
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $24.54 · Bull $30.00 · Bear $14.22
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-09 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $29.43
Why
Momentum59 · Δ7d +16.4
Value60 · Δ7d +0.2
Sentiment48 · Δ7d -3.2
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
59
26% active weight
Current posture
7d trendSoftening
Δ7d
+16.4
Δ21d
+12.8
Value
60
39% active weight
Current posture
7d trendFlat
Δ7d
+0.2
Δ21d
+0.6
Sentiment
48
34% active weight
Current posture
7d trendSoftening
Δ7d
-3.2
Δ21d
-3.7
Why this grade
Composite grade B. Momentum 59.4 / Value 60.5 / Sentiment 47.5
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$4.33B
Beta
1.01
Shares Out
162.73M
P/E (TTM)
269.7
P/S (TTM)
1.41
P/FCF (TTM)
14.13
Rev YoY
+14.4%
EPS YoY
+124.3%
Gross Margin
+55.3%
Op Margin
+7.2%
Net Debt
$386M
Current Ratio
2.44
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology